VIA
TYRA icon

Virtus Investment Advisers’s Tyra Biosciences TYRA Stock Holding History

Virtus Investment Advisers’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$461K Buy
12,049
+293
+2% +$9.48K 0.13% 227
2025
Q4 		$309K Buy
11,756
+741
+7% +$13.6K 0.08% 251
2025
Q3 		$154K Buy
11,015
+1,912
+21% +$21.8K 0.04% 372
2025
Q2 		$87.1K Sell
9,103
-1,715
-16% -$16.3K 0.03% 396
2025
Q1 		$101K Buy
+10,818
New +$140K 0.03% 419

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Virtus Investment Advisers's TYRA Position: Q1 2026 in Review

Virtus Investment Advisers increased its Tyra Biosciences (TYRA) stake by 2.5% in Q1 2026, buying an estimated $9.48K and bringing the position to 12,049 shares worth $461K. The position accounts for 0.13% of the portfolio, ranked #227.

Virtus Investment Advisers first reported a position in TYRA in Q1 2025 and has held it in 5 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Virtus Investment Advisers held 12,049 shares of Tyra Biosciences worth $461K as of Q1 2026.
  • Virtus Investment Advisers bought 293 Tyra Biosciences shares in Q1 2026, an estimated $9.48K.
  • Tyra Biosciences made up 0.13% of Virtus Investment Advisers's portfolio in Q1 2026, its #227 holding.
  • Virtus Investment Advisers first reported a position in Tyra Biosciences in Q1 2025 and has held it in 5 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.